Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.
about
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.Recent advances in the understanding of mastocytosis: the role of KIT mutations.Advances in targeted therapy for chronic myeloid leukemia.The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaImatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance.Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.Riddle: what do aplastic anemia, acute promyelocytic leukemia, and chronic myeloid leukemia have in common?Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib.Targeting developmental pathways in children with cancer: what price success?Current status of therapy for chronic myeloid leukemia: a review of drug development.Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F.Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors.Use of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukemia: translating preclinical findings to clinical practice.Insights into the stem cells of chronic myeloid leukemia.Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.Karyotypic findings in chronic myeloid leukemia cases undergoing treatment.Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib.Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome.GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid.Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib.Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases.Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib.Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods.Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance?Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib.Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.The Philadelphia translocation and pre-existing myeloproliferative disorders.
P2860
Q27853066-2D589C91-0A09-4D8E-B7CF-EB14D25EEF77Q33518973-1AF125C4-F19C-41FD-9085-710CB1F660CDQ33750753-B2E6FBE4-28B2-4EE4-A882-D79FA889B9DBQ33861815-098974CF-BAB0-4B58-AA02-E798F784A890Q34635424-2FBA3DFB-4AD0-4458-B447-E1005D76D8C4Q35160190-1FFCDF8C-B8D6-4E4E-A968-B3E9916CA7C6Q35628978-A201A824-0B1A-4DBA-91E0-E8ECC159179FQ35816396-85234AB3-6BD9-48B0-B8C6-0BCF54F823D6Q35849776-6CB0C1C4-6346-4573-83F5-C120C8BDC16AQ35882311-5EF0B172-B16F-4809-817D-9030B3C84110Q35932022-F8E8D1D1-1A9F-4430-893A-95CA369FB55DQ36905620-2C67BD8A-091B-42D7-B5D0-4C4EB038B102Q37179388-589FA6A6-806A-40FB-A229-AE7B3BFB295AQ37280862-B3C96C19-88D1-4D38-B989-7BE09CDD9312Q37356617-C2444DD2-A718-4C4F-9B0A-C1A8726F5C76Q37389361-58A51653-A1F2-421D-A94B-D5E936FEDC26Q37651599-B0FE12C0-AFE4-46BD-82E4-3EB5F393004FQ37663655-E9E27CAF-1E4F-4FC6-B04A-73690D6EA693Q37791423-79220B63-7566-4411-8BE7-B96A161CEC1FQ38447382-4D55E17D-38FD-4F8F-868B-FD4A0C210466Q38685696-E9001F9B-F5F6-4A41-B945-981D03998848Q42149644-E1EB7B18-7CAE-4D65-B7EE-C61038720994Q42650776-C6D89425-1692-41EA-AF53-4C70308B17A5Q42665076-F074F02A-58BC-491D-9282-EB59AE4FDBE5Q43266877-E97E265F-EA66-40E9-AA54-31532C79198DQ43291755-5448D836-933D-4306-A9B7-5B0A5A944AF2Q44569938-E69878B8-7B63-4BCD-BF8B-662944075C71Q44582792-928234C5-37CF-40AA-AC05-F32963D68E84Q44598656-FCEA0EC4-9FD6-4832-A749-14991EA9A089Q44605528-1FD29634-6EA0-441D-9C3F-AC3B32A868FDQ44653701-F433B9BA-49B6-43C6-9C20-3E600E9B3B9CQ44763544-72F4936D-6336-480A-BDC6-B3EFAE5BBE56Q44802309-3ECDA5DB-6AA8-4B75-A644-80393D360736Q44804346-E5D64DA4-CDFA-41CD-97BD-F5E4DAEBB4A7Q44845283-9E7BD9E5-BB05-4F50-90AE-79D3684079B5Q45043877-D84E124D-2A8F-4E94-A03D-03F0D12864D6Q45112330-C2A1EBDB-2AA3-4D05-A3A3-774F6858E227Q45201448-BB5CA67F-83A2-4E4F-80CD-D7FF797E6852Q45206587-7F54F3C6-AB06-4361-BAAE-C8B23415FB23Q45278087-A4671E4A-2B63-42F6-AF92-DADF752B6763
P2860
Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@en
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@nl
type
label
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@en
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@nl
prefLabel
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@en
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@nl
P2093
P1433
P1476
Emergence of clonal cytogeneti ...... hematopoiesis in the majority.
@en
P2093
Christel Müller
Christina Franke
Dietger Niederwieser
Erika Schmidt
Evelin Hennig
Haifa-Kathrin Al-Ali
Knut Krohn
Michael W N Deininger
Patricia Shepherd
Reiner Krahl
P304
P356
10.1182/BLOOD-2002-07-2053
P407
P577
2002-10-31T00:00:00Z